Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 casesB. Vergier, Jean‐Philippe Merlio, Martina Prochazkova‐Carlotti et al.|Modern Pathology|2010Cited by 140
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulationOlivier Kosmider, Benjamin Terrier, Marine Luka et al.|Nature Communications|2024Cited by 87
Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti–PD-1 TherapyL. Dousset, Lise Boussemart, F. Poizeau et al.|JCO Precision Oncology|2021Cited by 61
Immunohistochemistry as a potential tool for routine detection of the NRAS Q61R mutation in patients with metastatic melanomaMarius Ilié, Paul Hofman, Élodie Long-Mira et al.|Journal of the American Academy of Dermatology|2015Cited by 38
Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapyFrantz Dupuis, B. Vergier, Laurence Lamant et al.|British Journal of Cancer|2018Cited by 18